116 related articles for article (PubMed ID: 926781)
1. Inhibition of prostatic 5alpha-reductase and 3alpha-hydroxysteroid dehydrogenase by two antiandrogens.
Dupuy GM; Roberts KD; Bleau G; Chapdelaine A
J Steroid Biochem; 1977 Nov; 8(11):1145-51. PubMed ID: 926781
[No Abstract] [Full Text] [Related]
2. Inhibition of 3 alpha-hydroxysteroid oxidoreductase and 5 alpha-reductase activity by antiandrogens and indomethacin in the rat prostate.
Fukabori Y; Takezawa Y; Yamanaka H; Honma S
Prostate; 1992; 21(4):255-67. PubMed ID: 1281319
[TBL] [Abstract][Full Text] [Related]
3. Expression and characterization of recombinant type 2 3 alpha-hydroxysteroid dehydrogenase (HSD) from human prostate: demonstration of bifunctional 3 alpha/17 beta-HSD activity and cellular distribution.
Lin HK; Jez JM; Schlegel BP; Peehl DM; Pachter JA; Penning TM
Mol Endocrinol; 1997 Dec; 11(13):1971-84. PubMed ID: 9415401
[TBL] [Abstract][Full Text] [Related]
4. Gossypol inhibits 5α-reductase 1 and 3α-hydroxysteroid dehydrogenase: Its possible use for the treatment of prostate cancer.
Cao S; Wang G; Ge F; Li X; Zhu Q; Ge RS; Wang Y
Fitoterapia; 2019 Mar; 133():102-108. PubMed ID: 30605780
[TBL] [Abstract][Full Text] [Related]
5. Sex-specific action of antiandrogens on androgen induced changes in hepatic microsomal 3 beta-hydroxysteroid dehydrogenase and 5 alpha-reductase activity in the rat.
Lax ER; Schriefers H
Acta Endocrinol (Copenh); 1981 Oct; 98(2):261-6. PubMed ID: 6457494
[TBL] [Abstract][Full Text] [Related]
6. Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells.
Rizner TL; Lin HK; Peehl DM; Steckelbroeck S; Bauman DR; Penning TM
Endocrinology; 2003 Jul; 144(7):2922-32. PubMed ID: 12810547
[TBL] [Abstract][Full Text] [Related]
7. The action of 5 alpha-dihydrotestosterone and antiandrogens on the activities of 5 alpha-reductase and 3 alpha-hydroxysteroid dehydrogenase in the pituitary gland of gonadectomized rats.
Ghraf R; Schneider K; Kirchhoff J; Hiemke C
J Steroid Biochem; 1982 Apr; 16(4):545-52. PubMed ID: 6806544
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma.
Fung KM; Samara EN; Wong C; Metwalli A; Krlin R; Bane B; Liu CZ; Yang JT; Pitha JV; Culkin DJ; Kropp BP; Penning TM; Lin HK
Endocr Relat Cancer; 2006 Mar; 13(1):169-80. PubMed ID: 16601286
[TBL] [Abstract][Full Text] [Related]
9. Identification of the major oxidative 3alpha-hydroxysteroid dehydrogenase in human prostate that converts 5alpha-androstane-3alpha,17beta-diol to 5alpha-dihydrotestosterone: a potential therapeutic target for androgen-dependent disease.
Bauman DR; Steckelbroeck S; Williams MV; Peehl DM; Penning TM
Mol Endocrinol; 2006 Feb; 20(2):444-58. PubMed ID: 16179381
[TBL] [Abstract][Full Text] [Related]
10. 5 Alpha-reductase and 3 alpha-hydroxysteroid dehydrogenase activities in isolated canine prostatic epithelial cells.
McKercher G; Chevalier S; Roberts KD; Bleau G; Chapdelaine A
J Steroid Biochem; 1984 Nov; 21(5):549-54. PubMed ID: 6595475
[TBL] [Abstract][Full Text] [Related]
11. Androgen 5 alpha-reductase and 3 alpha-hydroxysteroid dehydrogenase activities in ventral prostate epithelial and stromal cells from immature and mature rats.
Orlowski J; Bird CE; Clark AF
J Endocrinol; 1983 Oct; 99(1):131-9. PubMed ID: 6579162
[TBL] [Abstract][Full Text] [Related]
12. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A
J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate.
Lin HK; Steckelbroeck S; Fung KM; Jones AN; Penning TM
Steroids; 2004 Dec; 69(13-14):795-801. PubMed ID: 15582534
[TBL] [Abstract][Full Text] [Related]
14. In vitro inhibition of testicular delta 5-3 beta-hydroxysteroid dehydrogenase and prostatic 5 alpha-reductase activities in rats and humans by strogen forte extract.
Tóth I; Szécsi M; Julesz J; Faredin I; Behnke B
Int Urol Nephrol; 1996; 28(3):337-48. PubMed ID: 8899474
[TBL] [Abstract][Full Text] [Related]
15. Hormonal and morphologic evaluation of the effects of antiandrogens on the blood supply of the rat prostate.
Shibata Y; Ono Y; Kashiwagi B; Suzuki K; Fukabori Y; Honma S; Yamanaka H
Urology; 2003 Nov; 62(5):942-6. PubMed ID: 14624931
[TBL] [Abstract][Full Text] [Related]
16. 2,3,7,8-tetrachlorodibenzo-p-dioxin inhibits luminal cell differentiation and androgen responsiveness of the ventral prostate without inhibiting prostatic 5alpha-dihydrotestosterone formation or testicular androgen production in rat offspring.
Theobald HM; Roman BL; Lin TM; Ohtani S; Chen SW; Peterson RE
Toxicol Sci; 2000 Dec; 58(2):324-38. PubMed ID: 11099645
[TBL] [Abstract][Full Text] [Related]
17. Structure-function aspects and inhibitor design of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3).
Penning TM; Burczynski ME; Jez JM; Lin HK; Ma H; Moore M; Ratnam K; Palackal N
Mol Cell Endocrinol; 2001 Jan; 171(1-2):137-49. PubMed ID: 11165022
[TBL] [Abstract][Full Text] [Related]
18. Increased ratio of 5 alpha-reductase: 3 alpha (beta)-hydroxysteroid dehydrogenase activities in the hyperplastic human prostate.
Bruchovsky N; Lieskovsky G
J Endocrinol; 1979 Mar; 80(3):289-301. PubMed ID: 86594
[TBL] [Abstract][Full Text] [Related]
19. Steroidal antiandrogens and 5alpha-reductase inhibitors.
Bratoeff E; Ramírez E; Murillo E; Flores G; Cabeza M
Curr Med Chem; 1999 Dec; 6(12):1107-23. PubMed ID: 10519917
[TBL] [Abstract][Full Text] [Related]
20. Approaches to prostatic 5 alpha-reductase inhibitors.
Batzold FH
Prog Clin Biol Res; 1981; 75B():269-82. PubMed ID: 6172801
[No Abstract] [Full Text] [Related]
[Next] [New Search]
